Clinical trial

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

NCT00019084

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention aldesleukin Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention mutant p53 peptide pulsed dendritic cell vaccine Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention ras peptide cancer vaccine Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention sargramostim Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention therapeutic autologous lymphocytes Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention therapeutic tumor infiltrating lymphocytes Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1996-02-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Cervical Cancerverified · MONDO: cervical cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Lung Cancerverified · MONDO: lung cancer

Ovarian Cancerverified · MONDO: ovarian cancer

Pancreatic Cancerverified · MONDO: malignant pancreatic neoplasm

Interventions

aldesleukinBIOLOGICAL

mutant p53 peptide pulsed dendritic cell vaccineBIOLOGICAL

ras peptide cancer vaccineBIOLOGICAL

sargramostimBIOLOGICAL

therapeutic autologous lymphocytesBIOLOGICAL

therapeutic tumor infiltrating lymphocytesBIOLOGICAL

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00019084 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.